Daily Financial Update Market Pulse: U.S. benchmarks drifted in a narrow range yesterday, buoyed by...
Archive - April 2, 2026
RARE: Positive DTX301 Phase 3 Results Spark Investor Interest!
Overview of DTX301 Phase 3 Breakthrough Ultragenyx Pharmaceutical (NASDAQ: RARE), a biotech focused...